Affordable Access

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.

Authors
Type
Published Article
Journal
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Publication Date
Volume
179
Issue
1
Pages
16–20
Identifiers
PMID: 12540980
Source
Medline
License
Unknown

Abstract

Patients with four or more brain metastases seem to represent a group with unfavorable prognosis where remission of brain metastases or administration of more than 30 Gy were not associated with increased survival. The number of patients in RPA class I was too small to draw final conclusions. However, there was absolutely no survival difference between patients in class II (median survival 3.6 months) and III (median 4.2 months).

Statistics

Seen <100 times